Sun Pharma gets US FDA nod for generic lenalidomide capsules EP News Bureau Feb 10, 2023 The respective product approval is based on Revlimid Capsules, 5 mg, 10 mg, 15 mg, 25 mg and 2.5 mg, 20 mg as a reference product
Cipla gets US FDA nod for cancer drug Press Trust of India Sep 8, 2022 Cipla's Lenalidomide capsules are therapeutic equivalent generic version of Bristol Myers Squibb's Revlimid (Lenalidomide)…
Natco Pharma gets USFDA approval for lenalidomide capsules EP News Bureau May 22, 2021 They are used to treat various types of cancers
Dr Reddy’s announces settlement of Revlimid capsules patent litigation with Celgene in US EP News Bureau Sep 17, 2020 Celgene has agreed to provide Dr Reddy’s with a license to sell volume-limited amounts of generic lenalidomide capsules in the US…